Report: Florida HMOs slammed for denying cholesterol drugs

Florida health plans on average reject 45 percent of the claims claims submitted for coverage of prescribed advanced cholesterol lowering drugs, according to the advocacy group known as Institute for Patient Access.

The institute released a report card highlighting the rates at which Florida insurers deny patients coverage for the medications, known as PCSK9 inhibitors.

More at Politico.